Both mRNA and protein expression of TGF-β1 have been extensively investigated in a series of human cancers, including thyroid cancer; however, the potential of TGF-β1 as a clinical tool for the diagnosis and prognosis of thyroid tumors has not been thoroughly investigated. Here, TGFB1 is linked to thyroid gland carcinoma.